Based on the results of preclinical studies, clinical studies have been conducted, which also demonstrated that ABCB5 + MSCs can reduce the RDEB severity and heal chronic wounds [119,125,126,127]. This evidence concerns the gene ABCB5 and recessive dystrophic epidermolysis bullosa.